Clorinda Walley, President & CEO of Good Days, on Patient Assistance Funding | Plus, Image of the Month with Prof. Paulo Stanga: Papillophlebitis on the Silverstone RGB

Guests: Clorinda Walley – President & CEO, Good Days | Prof. Paulo Stanga – Founder & Chief Medical Officer, The Retina Clinic London; Professor of Ophthalmology, UCL Institute of OphthalmologyShow SummaryThis episode of RetinUp pulls back the curtain on Good Days, one of the most important — and least understood — resources in retina practice. Clorinda Walley, Good Days President & CEO, joins John and Scott to explain how the organization works, how it's funded, who qualifies, and what retina specialists can do to help sustain it. The conversation covers everything from the mechanics of fund allocation to the policy threats currently on Good Days's radar.The episode then moves to the inaugural Image of the Month, featuring Prof. Paulo Stanga, who presents a case of papillophlebitis initially referred as a branch retinal vein occlusion. The case demonstrates how ultra-widefield RGB imaging with the Optos Silverstone RGB changed the clinical picture before the patient ever entered the exam room.Hosts: John Kitchens, MD, and Scott KrzywonosTopics CoveredGood Days in 2026 (Clorinda Walley)What is Good Days?Types of assistance (copay, premium, and travel support across multiple disease categories) and who is eligible for supportFunding sources for Good DaysHow retinal vascular disease assistance operates separately from GA assistance What happens when a program is funded—and when funding runs outGood Days’ advocacy in DC and beyondGetting your patients enrolled in Good DaysImage of the Month: Papillophlebitis (Prof. Paulo Stanga)Case presentation: patient referred for a clinical trial with presumed branch retinal vein occlusionUltra-widefield RGB imaging with the Optos Silverstone upon referral Final diagnosis: papillophlebitis Clinical workflow advantages of pre-visit imagingKey TakeawaysGood Days is a critical safety net for Medicare patients who cannot afford their retinal treatments, but its programs depend entirely on ongoing donations — funding can close without warning.Retina specialists can directly support Good Days by getting on the notification list, posting donation signage, and advocating with pharma partners for continued funding.Retina practice as we know it is supported by Good Days—but Good Days itself is only around as long as their donation base shows up. Ultra-widefield imaging captured early in an appointment changes clinical workflow: Prof. Stanga's case demonstrates that RGB imaging can redirect a diagnosis before the physician enters the room.True-color RGB ultra-widefield imaging with swept-source OCT provides a more complete picture of the retina than two-channel systems, particularly at the vitreoretinal interface and in patients with media opacity.SponsorsRetinUp is an editorially independent podcast supported with advertising. This episode is sponsored by Ocular Therapeutix. Learn more at OCUTX.com.This episode is sponsored by Genentech, maker of Vabysmo (faricimab-svoa). Watch the Purple Chair series at Vabysmo-HCP.com.The images featured in this episode were captured using the Optos Silverstone RGB. Learn more about Silverstone RGB at Optos.com/products/silverstone.Credits Production & Marketing: Laura Brown | Business Operations: Liz Hogan Listen at RetinUp.com | Apple Podcasts | Spotify | YouTube